Trial · NCT07907003
Robot-Assisted Tabletop Games for Community-Dwelling Older Adults
NCT07907003, Not applicable, Completed, Chang Gung University of Science and Technology
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Robot-Assisted Tabletop Games for Community-Dwelling Older Adults. Trials, record NCT07907003. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907003
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Robot-Assisted Tabletop Games for Community-Dwelling Older Adults
- NCT number
- NCT07907003
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 93 participants, actual
- Lead sponsor
- Chang Gung University of Science and Technology
- Conditions
- Healthy Aging, Cognitive Function 1, Social, Physical Function in Older Adults
- Interventions
- Robot-Assisted Tabletop Game Program
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Physical Performance Assessed by the Short Physical Performance Battery (SPPB) | Baseline and immediately after the 12-week intervention | Physical performance was assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, gait speed, and repeated chair-rise tasks. Total scores range from 0 to 12, with higher scores indicating better physical performance. Change was assessed from baseline to the end of the 12-week intervention. |
| Primary | Change in Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA) | Baseline and immediately after the 12-week intervention | Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), which evaluates executive and visuospatial function, naming, attention, language, abstraction, memory, and orientation. Total scores range from 0 to 30, with higher scores indicating better cognitive performance. Change was assessed from baseline to the end of the 12-week intervention. |
| Primary | Change in Subjective Well-Being Assessed by the Well-Being Scale | Baseline and immediately after the 12-week intervention | Subjective well-being was assessed using the 14-item Well-Being Scale for older adults in Taiwan. The scale includes life-satisfaction and positive-affect dimensions and uses a four-point Likert response format. Higher total scores indicate greater subjective well-being. Change was assessed from baseline to the end of the 12-week intervention. |
| Secondary | ADL | Baseline and immediately after the 12-week intervention | Change in Activities of Daily Living Assessed by the Barthel Index |
| Secondary | IADL | Baseline and immediately after the 12-week intervention | Change in Instrumental Activities of Daily Living (IADL) |
| Secondary | MMSE | Baseline and immediately after the 12-week intervention | Change in Global Cognitive Function Assessed by the Mini-Mental State Examination (MMSE) |
| Secondary | GDS-SF | Baseline and immediately after the 12-week intervention | Change in Depressive Symptoms Assessed by the Geriatric Depression Scale-Short Form (GDS-SF) |
| Secondary | SOF | Baseline and immediately after the 12-week intervention | Change in Frailty Status Assessed by the Study of Osteoporotic Fractures (SOF) Frailty Index |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907003
GET https://conductscience.org/api/trials/v1/NCT07907003/registered